查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1760591

2025年全球白血球分离术市场报告

Leukapheresis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，白血球分离术市场规模将强劲成长。预计到2029年，该市场规模将达到978.3亿美元，复合年增长率为7.9%。预测期内的成长预计将受到以下因素的推动：个人化细胞疗法需求的不断增长、免疫肿瘤学临床试验的增多、再生医学应用的日益普及、生物製药生产规模的扩大、报销政策的完善以及人们对基于细胞的研究和治疗方案的认识的不断提高。预测期内的主要趋势包括细胞分离技术的开发、人工智慧在流程优化中的应用、可携式白血球分离设备的开发、细胞和基因疗法的进步、供体筛检方法的改进以及云端基础数据追踪系统的普及。

自体免疫疾病的日益普及预计将推动白血球分离术市场的扩张。当免疫系统错误地攻击身体的健康组织时，就会引发自体免疫疾病。童年时期接触微生物的机会减少以及现代环境的影响等因素破坏了免疫平衡，导致自体免疫疾病的发生率上升。白血球分离术透过选择性地清除那些帮助免疫系统攻击身体的有害白血球，从而帮助治疗这些疾病。例如，根据德国机构Versorgungsatlas.de的报告，2022年，在73,241,305名参保人员中，有6,304,340人被诊断出患有至少一种自体免疫疾病，盛行率为8.61%。因此，自体免疫疾病的增多正在推动白血球分离术市场的成长。

白血球分离术市场的主要企业正专注于创新，例如开发GMP级隐色，以提高细胞疗法生产的品质和效率。 GMP级隐色是指根据严格的良好生产规范 (GMP) 标准加工的白血球分离术衍生产品，确保细胞的高活力和治疗功能。例如，2024年11月，美国生物技术公司Sanguine Biosciences推出了LeukoCer，这是隐色GMP级白血球分离包，旨在简化工作流程并加快细胞疗法的开发。 LeukoCer提供按照严格GMP标准生产的新鲜整包或半包高品质起始材料，使研究人员能够推进研究并加速新型细胞疗法的市场推广。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球白血球分离术的 PESTEL 分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球白血球分离疗法市场：成长率分析
  • 全球白血球分离术市场表现：规模与成长，2019-2024 年
  • 全球白血球分离术市场预测：规模与成长，2024-2029 年，2034 年
  • 全球白血球分离疗法总目标市场（TAM）

第六章市场区隔

  • 全球白血球分离术市场类型、绩效及预测（2019-2024、2024-2029、2034）
  • 粒细胞成分分析
  • 淋巴球成分分析
  • 单核细胞成分分析
  • 全球白血球分离术市场（依产品、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 白血球分离装置
  • 离心装置
  • 膜分离器
  • 白血球分离术一次性用品
  • 全球白血球分离疗法市场的应用、绩效及预测（2019-2024、2024-2029、2034）
  • 研究应用
  • 癌症研究
  • 免疫学研究
  • 治疗应用
  • 血液系统疾病
  • 自体免疫疾病
  • 其他的
  • 全球白血球分离疗法市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 血液成分供应商和血液中心
  • 学术研究所
  • 製药和生物技术公司
  • 医院/输血中心
  • 全球白血球分离术市场：粒细胞成分分析细分（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 嗜中性白血球球成分分析
  • 嗜酸性粒细胞细胞成分分析
  • 嗜碱性球成分分析
  • 全球白血球分离疗法市场：淋巴球成分分析细分（按类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • T细胞成分分析
  • B细胞成分分析
  • 自然杀手（NK）细胞成分分析
  • 全球白血球分离术市场：单核细胞成分分析细分（按类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 经典单核细胞
  • 非经典单核细胞
  • 中间单核细胞

第七章 区域和国家分析

  • 全球白血球分离疗法市场（按地区、绩效及预测）2019-2024、2024-2029、2034
  • 全球白血球分离疗法市场（依国家/地区、绩效及预测）2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 白血球分离术市场：竞争格局
  • 白血球分离术市场：公司简介
    • Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
    • Grifols SA Overview, Products and Services, Strategy and Financial Analysis
    • Terumo BCT Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Nikkiso Co. Overview, Products and Services, Strategy and Financial Analysis
    • STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Haemonetics Corporation
  • Macopharma
  • Discovery Life Sciences
  • BioIVT LLC
  • StemExpress LLC
  • MEDICA SpA
  • AllCells LLC
  • Caltag Medsystems Ltd.
  • Miltenyi Biotec
  • Immune Therapy Holdings AB
  • Cellsep Laboratories
  • Accegen Biotec
  • Key Biologics LLC
  • HemaCare Corporation
  • Puriblood Medical

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年白血球分离术市场：提供新机会的国家
  • 2029 年白血球分离术市场：细分领域带来新机会
  • 2029 年白血球分离术市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r35468

Leukapheresis is a medical procedure that involves the separation and removal of white blood cells (leukocytes) from a patient's blood. The remaining blood components, such as red blood cells and plasma, are then returned to the body. This technique is used to treat conditions with elevated white blood cell counts or to collect specific immune cells for research or therapeutic purposes.

The main types of leukapheresis include granulocyte, lymphocyte, and monocyte apheresis. Granulocyte apheresis is a procedure that selectively isolates granulocytes (a type of white blood cell) from a patient's blood for therapeutic use. Products related to this procedure include leukapheresis devices, centrifugal devices, membrane separators, and disposables. Applications of leukapheresis extend to research areas such as cancer research, immunology, hematologic disorders, autoimmune diseases, and others. These procedures are utilized by blood component providers, blood centers, academic and research institutions, pharmaceutical and biotechnology companies, and hospitals and transfusion centers.

The leukapheresis market research report is one of a series of new reports from The Business Research Company that provides leukapheresis market statistics, including the leukapheresis industry global market size, regional shares, competitors with the leukapheresis market share, detailed leukapheresis market segments, market trends, and opportunities, and any further data you may need to thrive in the leukapheresis industry. This leukapheresis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The leukapheresis market size has grown strongly in recent years. It will grow from $66.80 billion in 2024 to $72.23 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. Growth during the historic period can be attributed to the increasing prevalence of leukemia and autoimmune diseases, rising demand for personalized medicine, advancements in stem cell research, improvements in apheresis technologies, expanding clinical trial activities, and greater awareness of immunotherapy applications.

The leukapheresis market size is expected to see strong growth in the next few years. It will grow to $97.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. Growth in the forecast period is expected to be driven by rising demand for personalized cell therapies, an increase in clinical trials in immuno-oncology, growing adoption in regenerative medicine, expansion of biopharmaceutical manufacturing, improved reimbursement policies, and greater awareness of cell-based research and treatment options. Key trends in the forecast period include advancements in cell separation technologies, integration of AI for optimizing procedures, development of portable leukapheresis devices, progress in cell and gene therapy, enhanced donor screening methods, and the adoption of cloud-based data tracking systems.

The growing incidence of autoimmune diseases is anticipated to drive the expansion of the leukapheresis market. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy tissues. Factors such as reduced early-life microbial exposure and modern environmental influences are disrupting immune balance, leading to an increase in autoimmune disorders. Leukapheresis aids in treating these diseases by selectively removing harmful white blood cells that contribute to the immune system's attack on the body. For example, according to a report by Versorgungsatlas.de, a Germany-based organization, in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a prevalence rate of 8.61%. Thus, the rise in autoimmune diseases is fueling the growth of the leukapheresis market.

Leading companies in the leukapheresis market are focusing on innovations such as the development of GMP-grade leukopaks to improve the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are leukapheresis-derived products processed under stringent good manufacturing practice (GMP) standards, ensuring high cell viability and functionality for therapeutic use. For instance, in November 2024, Sanguine Biosciences, a US-based biotechnology company, introduced LeukoCer, a GMP-grade leukopak designed to streamline workflows and speed up cell therapy development. LeukoCer provides high-quality starting materials in fresh whole or half packs, produced according to strict GMP standards, enabling researchers to advance their work and accelerate the introduction of new cell therapies to the market.

In July 2023, SCTbio, a Czech Republic-based contract development and manufacturing organization, formed a partnership with Cyto-care.eu GmbH to enhance the cryopreservation process for cell therapy in Europe. The collaboration focuses on improving the collection, cryopreservation, quality control, and logistics of leukapheresis materials, which are vital components in the production of advanced cell therapy products (ATMPs). Cyto-care.eu GmbH, based in Austria, specializes in providing cell products for biomedical research, drug discovery, and cell and gene therapy.

Major players in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., STEMCELL Technologies Inc., Haemonetics Corporation, Macopharma, Discovery Life Sciences, BioIVT LLC, StemExpress LLC, MEDICA S.p.A, AllCells LLC, Caltag Medsystems Ltd., Miltenyi Biotec, Immune Therapy Holdings AB, Cellsep Laboratories, Accegen Biotec, Key Biologics LLC, HemaCare Corporation, Puriblood Medical, Cytopheron Technologies, and Adacyte Therapeutics.

North America was the largest region in the leukapheresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in leukapheresis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the leukapheresis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leukapheresis market consists of revenues earned by entities providing services such as cell collection, cell processing and storage, and custom apheresis procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The leukapheresis market also includes sales of products such as apheresis machines, centrifugal and membrane-based systems, needles & catheters, and anticoagulants and solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukapheresis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on leukapheresis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukapheresis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The leukapheresis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Granulocyte Apheresis; Lymphocyte Apheresis; Monocyte Apheresis
  • 2) By Product: Leukapheresis Devices; Centrifugal Devices; Membrane Separators; Leukapheresis Disposables
  • 3) By Application: Research Application; Cancer Research; Immunology Research; Therapeutics Application; Hematologic Disorders; Autoimmune Diseases; Other Applications
  • 4) By End User: Blood Component Providers And Blood Centers; Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Transfusion Centers
  • Subsegments:
  • 1) By Granulocyte Apheresis: Neutrophil Apheresis; Eosinophil Apheresis; Basophil Apheresis
  • 2) By Lymphocyte Apheresis: T-Cell Apheresis; B-Cell Apheresis; Natural Killer (NK) Cell Apheresis
  • 3) By Monocyte Apheresis: Classical Monocytes; Non-Classical Monocytes; Intermediate Monocytes
  • Companies Mentioned: Fresenius Kabi; Grifols S.A.; Terumo BCT Inc.; Nikkiso Co.; STEMCELL Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Leukapheresis Market Characteristics

3. Leukapheresis Market Trends And Strategies

4. Leukapheresis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Leukapheresis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Leukapheresis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Leukapheresis Market Growth Rate Analysis
  • 5.4. Global Leukapheresis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Leukapheresis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Leukapheresis Total Addressable Market (TAM)

6. Leukapheresis Market Segmentation

  • 6.1. Global Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Granulocyte Apheresis
  • Lymphocyte Apheresis
  • Monocyte Apheresis
  • 6.2. Global Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Leukapheresis Devices
  • Centrifugal Devices
  • Membrane Separators
  • Leukapheresis Disposables
  • 6.3. Global Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Application
  • Cancer Research
  • Immunology Research
  • Therapeutics Application
  • Hematologic Disorders
  • Autoimmune Diseases
  • Other Applications
  • 6.4. Global Leukapheresis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Component Providers And Blood Centers
  • Academic And Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Transfusion Centers
  • 6.5. Global Leukapheresis Market, Sub-Segmentation Of Granulocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neutrophil Apheresis
  • Eosinophil Apheresis
  • Basophil Apheresis
  • 6.6. Global Leukapheresis Market, Sub-Segmentation Of Lymphocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • T-Cell Apheresis
  • B-Cell Apheresis
  • Natural Killer (NK) Cell Apheresis
  • 6.7. Global Leukapheresis Market, Sub-Segmentation Of Monocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Classical Monocytes
  • Non-Classical Monocytes
  • Intermediate Monocytes

7. Leukapheresis Market Regional And Country Analysis

  • 7.1. Global Leukapheresis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Leukapheresis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leukapheresis Market

  • 8.1. Asia-Pacific Leukapheresis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leukapheresis Market

  • 9.1. China Leukapheresis Market Overview
  • 9.2. China Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leukapheresis Market

  • 10.1. India Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leukapheresis Market

  • 11.1. Japan Leukapheresis Market Overview
  • 11.2. Japan Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leukapheresis Market

  • 12.1. Australia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leukapheresis Market

  • 13.1. Indonesia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leukapheresis Market

  • 14.1. South Korea Leukapheresis Market Overview
  • 14.2. South Korea Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leukapheresis Market

  • 15.1. Western Europe Leukapheresis Market Overview
  • 15.2. Western Europe Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leukapheresis Market

  • 16.1. UK Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leukapheresis Market

  • 17.1. Germany Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leukapheresis Market

  • 18.1. France Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leukapheresis Market

  • 19.1. Italy Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leukapheresis Market

  • 20.1. Spain Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leukapheresis Market

  • 21.1. Eastern Europe Leukapheresis Market Overview
  • 21.2. Eastern Europe Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leukapheresis Market

  • 22.1. Russia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leukapheresis Market

  • 23.1. North America Leukapheresis Market Overview
  • 23.2. North America Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leukapheresis Market

  • 24.1. USA Leukapheresis Market Overview
  • 24.2. USA Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leukapheresis Market

  • 25.1. Canada Leukapheresis Market Overview
  • 25.2. Canada Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leukapheresis Market

  • 26.1. South America Leukapheresis Market Overview
  • 26.2. South America Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leukapheresis Market

  • 27.1. Brazil Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leukapheresis Market

  • 28.1. Middle East Leukapheresis Market Overview
  • 28.2. Middle East Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leukapheresis Market

  • 29.1. Africa Leukapheresis Market Overview
  • 29.2. Africa Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leukapheresis Market Competitive Landscape And Company Profiles

  • 30.1. Leukapheresis Market Competitive Landscape
  • 30.2. Leukapheresis Market Company Profiles
    • 30.2.1. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Terumo BCT Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Nikkiso Co. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Leukapheresis Market Other Major And Innovative Companies

  • 31.1. Haemonetics Corporation
  • 31.2. Macopharma
  • 31.3. Discovery Life Sciences
  • 31.4. BioIVT LLC
  • 31.5. StemExpress LLC
  • 31.6. MEDICA S.p.A
  • 31.7. AllCells LLC
  • 31.8. Caltag Medsystems Ltd.
  • 31.9. Miltenyi Biotec
  • 31.10. Immune Therapy Holdings AB
  • 31.11. Cellsep Laboratories
  • 31.12. Accegen Biotec
  • 31.13. Key Biologics LLC
  • 31.14. HemaCare Corporation
  • 31.15. Puriblood Medical

32. Global Leukapheresis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leukapheresis Market

34. Recent Developments In The Leukapheresis Market

35. Leukapheresis Market High Potential Countries, Segments and Strategies

  • 35.1 Leukapheresis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Leukapheresis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Leukapheresis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer